vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and UDR, Inc. (UDR). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $425.8M, roughly 1.2× UDR, Inc.). UDR, Inc. runs the higher net margin — 44.6% vs 6.8%, a 37.8% gap on every dollar of revenue. On growth, UDR, Inc. posted the faster year-over-year revenue change (0.9% vs -1.7%). Over the past eight quarters, UDR, Inc.'s revenue compounded faster (1.3% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
UDR, Inc. is a leading U.S.-headquartered real estate investment trust specializing in owning, operating, and redeveloping high-quality multifamily residential apartment communities. It operates across major U.S. metropolitan markets, catering to a diverse tenant base including young professionals, families, and middle-to-high income households.
MD vs UDR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $425.8M |
| Net Profit | $33.7M | $189.8M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 54.0% |
| Net Margin | 6.8% | 44.6% |
| Revenue YoY | -1.7% | 0.9% |
| Net Profit YoY | 10.5% | 147.2% |
| EPS (diluted) | $0.40 | $0.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $425.8M | ||
| Q4 25 | $493.8M | $433.1M | ||
| Q3 25 | $492.9M | $431.9M | ||
| Q2 25 | $468.8M | $425.4M | ||
| Q1 25 | $458.4M | $421.9M | ||
| Q4 24 | $502.4M | $422.7M | ||
| Q3 24 | $511.2M | $420.2M | ||
| Q2 24 | $504.3M | $415.3M |
| Q1 26 | — | $189.8M | ||
| Q4 25 | $33.7M | $222.9M | ||
| Q3 25 | $71.7M | $40.4M | ||
| Q2 25 | $39.3M | $37.7M | ||
| Q1 25 | $20.7M | $76.7M | ||
| Q4 24 | $30.5M | $-5.0M | ||
| Q3 24 | $19.4M | $22.6M | ||
| Q2 24 | $-153.0M | $28.9M |
| Q1 26 | — | 54.0% | ||
| Q4 25 | 9.9% | 64.1% | ||
| Q3 25 | 13.8% | 17.7% | ||
| Q2 25 | 12.8% | 18.2% | ||
| Q1 25 | 7.0% | 29.0% | ||
| Q4 24 | 7.8% | 15.7% | ||
| Q3 24 | 6.6% | 16.6% | ||
| Q2 24 | -31.3% | 16.5% |
| Q1 26 | — | 44.6% | ||
| Q4 25 | 6.8% | 51.5% | ||
| Q3 25 | 14.5% | 9.4% | ||
| Q2 25 | 8.4% | 8.9% | ||
| Q1 25 | 4.5% | 18.2% | ||
| Q4 24 | 6.1% | -220.5% | ||
| Q3 24 | 3.8% | 5.4% | ||
| Q2 24 | -30.3% | 7.0% |
| Q1 26 | — | $0.63 | ||
| Q4 25 | $0.40 | $0.67 | ||
| Q3 25 | $0.84 | $0.12 | ||
| Q2 25 | $0.46 | $0.11 | ||
| Q1 25 | $0.24 | $0.23 | ||
| Q4 24 | $0.37 | $-0.01 | ||
| Q3 24 | $0.23 | $0.06 | ||
| Q2 24 | $-1.84 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $1.3M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $3.3B |
| Total Assets | $2.2B | $10.3B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.3M | ||
| Q4 25 | $375.2M | $1.2M | ||
| Q3 25 | $340.1M | $1.2M | ||
| Q2 25 | $224.7M | $1.5M | ||
| Q1 25 | $99.0M | $1.3M | ||
| Q4 24 | $229.9M | $1.3M | ||
| Q3 24 | $103.8M | $2.3M | ||
| Q2 24 | $19.4M | $2.8M |
| Q1 26 | — | — | ||
| Q4 25 | $570.5M | $5.8B | ||
| Q3 25 | $577.2M | $5.8B | ||
| Q2 25 | $583.9M | $5.8B | ||
| Q1 25 | $590.5M | $5.8B | ||
| Q4 24 | $597.1M | $5.8B | ||
| Q3 24 | — | $5.9B | ||
| Q2 24 | — | $5.8B |
| Q1 26 | — | $3.3B | ||
| Q4 25 | $865.9M | $3.3B | ||
| Q3 25 | $890.7M | $3.3B | ||
| Q2 25 | $833.8M | $3.3B | ||
| Q1 25 | $789.2M | $3.3B | ||
| Q4 24 | $764.9M | $3.4B | ||
| Q3 24 | $732.5M | $3.5B | ||
| Q2 24 | $706.5M | $3.7B |
| Q1 26 | — | $10.3B | ||
| Q4 25 | $2.2B | $10.6B | ||
| Q3 25 | $2.2B | $10.6B | ||
| Q2 25 | $2.1B | $10.6B | ||
| Q1 25 | $2.0B | $10.7B | ||
| Q4 24 | $2.2B | $10.9B | ||
| Q3 24 | $2.1B | $11.1B | ||
| Q2 24 | $2.0B | $11.1B |
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | 1.77× | ||
| Q3 25 | 0.65× | 1.78× | ||
| Q2 25 | 0.70× | 1.74× | ||
| Q1 25 | 0.75× | 1.74× | ||
| Q4 24 | 0.78× | 1.69× | ||
| Q3 24 | — | 1.67× | ||
| Q2 24 | — | 1.55× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 4.9% |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $114.1M | $902.9M | ||
| Q3 25 | $137.3M | $234.9M | ||
| Q2 25 | $137.2M | $250.3M | ||
| Q1 25 | $-117.5M | $156.2M | ||
| Q4 24 | $133.0M | $876.8M | ||
| Q3 24 | $91.8M | $230.3M | ||
| Q2 24 | $107.0M | $238.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $650.0M | ||
| Q3 25 | — | $164.6M | ||
| Q2 25 | — | $190.1M | ||
| Q1 25 | — | $103.2M | ||
| Q4 24 | — | $627.0M | ||
| Q3 24 | — | $161.3M | ||
| Q2 24 | — | $171.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | 150.1% | ||
| Q3 25 | — | 38.1% | ||
| Q2 25 | — | 44.7% | ||
| Q1 25 | — | 24.5% | ||
| Q4 24 | — | 148.3% | ||
| Q3 24 | — | 38.4% | ||
| Q2 24 | — | 41.2% |
| Q1 26 | — | 4.9% | ||
| Q4 25 | — | 58.4% | ||
| Q3 25 | — | 16.3% | ||
| Q2 25 | — | 14.2% | ||
| Q1 25 | — | 12.6% | ||
| Q4 24 | — | 59.1% | ||
| Q3 24 | — | 16.4% | ||
| Q2 24 | — | 16.2% |
| Q1 26 | — | — | ||
| Q4 25 | 3.39× | 4.05× | ||
| Q3 25 | 1.91× | 5.81× | ||
| Q2 25 | 3.49× | 6.64× | ||
| Q1 25 | -5.66× | 2.04× | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | 10.19× | ||
| Q2 24 | — | 8.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
UDR
| Rental income | $423.3M | 99% |
| Joint venture management and other fees | $2.5M | 1% |
